The global cosmetic surgery products market is projected to reach a value of US$ 19.09 billion in 2023. Over the forecast period from 2023 to 2033, it is anticipated to demonstrate a CAGR of 8.1%, resulting in a total accumulation of US$ 41.64 billion by 2033.
The growth of the industry can be attributed to increasing awareness about cosmetic procedures among the young population and the availability of technologically advanced products to carry out various surgical procedures.
The advent of technologically developed equipment, like non-invasive body contouring systems, which employ fat-freezing technology, is likely to offer conducive growth opportunities to the market in the forthcoming decade. As per the Aesthetic Society of the U.S, in 2020, non-invasive body fat reduction was listed in the top 5 non-invasive procedures in the country with 140,314 procedures performed.
Attributes | Details |
---|---|
Historical Value (2022) | US$ 17.94 billion |
Current Year Value (2023) | US$ 19.09 billion |
Expected Forecast Value (2033) | US$ 41.64 billion |
Historical CAGR (2018 to 2022) | 5.3% |
Projected CAGR (2023 to 2033) | 8.1% |
Similarly, the American Society of Plastic Surgeons reveals, that in 2020, 13.2 million cosmetic minimally invasive procedures, 2.3 million cosmetic surgical procedures, and 6.8 million reconstructive procedures were performed in the United States, which was a surge of 3% against the 2019 procedures.
The rising expenses on cosmetics and the willingness to adopt novel cosmetic treatments are likely to drive the demand for cosmetic surgery and procedures in the coming time. Also, the approval of new products by authorities is likely to expand the market size in the coming time. In February 2021, FDA approved RESTYLANE DEFYNE for the correction of double chin reduction for adults over 21 years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing Fitness Consciousness among Millennial to Expand the Market
The market has been expanding past few years due to the increasing fitness desire among millennial. The technological advancement in devices and the rising demand for minimally invasive procedures are anticipated to boost the market significantly during the forecast period. According to the American Society of Plastic Surgeons, in 2020, 13,281,235 cosmetic minimally-invasive procedures were performed in the United States.
Moreover, the introduction of new products in the industry is anticipated to act as a significant propeller to the market expansion. For instance, Revance launched RHA (resilient hyaluronic acid) collection of fillers. Such factors, along with the growing awareness about cosmetic surgery are likely to boost the cosmetic surgery requirements in the forthcoming period.
Increasing cosmetic surgery demands have resulted in increased FDA approvals, which is likely to benefit the industry in the coming time. For instance, In June 2020, Allergan Aesthetics received the FDA approval of JUVÉDERM® VOLUMA™ XC for the enhancement of the chin region in adults over 21 years. Further, in 2019, the FDA approved Jeuveau, which is close to Botox. It is available at a lower cost as compared to Botox.
Increasing Demand for Non-Invasive Procedures to Offer Remunerative Opportunities to the Market
Growing demand for non-invasive procedures owing to various benefits offered such as less pain, instant results, and low cost will benefit the industry during the assessment period. Some of the popular non-invasive procedures include soft tissue fillers, Botox injections, and chemical peels. The availability of medical spas and specialty clinics providing these procedures is constantly rising. This factor has boosted the number of people opting for non-surgical procedures to enhance their physical appearance.
As per the American Society for Aesthetic Plastic Surgery (ASAPS), nose reshaping, eyelid surgery, and facelift were among the most performed surgical procedures in the USA in 2020.
Presence of Unregulated Market to Hamper the Market Growth
Various countries have experienced a rise in the number of illegal vendors providing cosmetic procedures and attracting a number of customers to undergo cosmetic procedures.
They’re un-registered medical practitioners and surgeons, which significantly impede the market in the assessment period. This has resulted in adverse effects of cosmetic surgery which have been linked with the presence of a regulated market which will hamper the market growth in the assessment period.
Segment | 2022 Value Share in Global Market |
---|---|
Cosmetic Surgery Products for Face | 66.4% |
Cosmetic Surgery Products for Clinics | 46.5% |
Cosmetic surgery products for the face dominate the cosmetic surgery market by the application due to several key factors. The face holds significant importance as the most visible part of the body, influencing first impressions and self-confidence. The rising concern about signs of aging, such as wrinkles and sagging skin, has fueled the demand for facial cosmetic procedures like facelifts, Botox, and dermal fillers. Additionally, the advent of social media and selfie culture has heightened self-awareness, leading to a surge in facial enhancements to present an aesthetically pleasing image online.
Non-invasive or minimally invasive facial treatments, with less downtime and fewer risks, have broadened the target audience seeking cosmetic enhancements. Celebrity endorsements and media coverage have also played a role in driving the popularity of facial procedures. While cultural influences and beauty standards vary, many cultures place a strong emphasis on facial features, further increasing the demand for facial cosmetic products.
The clinics segment dominates the market. Cosmetic surgery clinics specialize exclusively in aesthetic procedures, ensuring a focused and personalized experience for patients. Their medical professionals are often highly experienced in cosmetic surgery, instilling confidence in potential customers. Moreover, the streamlined operations of clinics lead to shorter wait times and more efficient scheduling, adding to patient convenience. Over time, reputable clinics can build strong brand recognition, bolstered by positive reviews and word-of-mouth referrals. Privacy and discretion are also critical factors, with patients often preferring the relative seclusion offered by clinics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
North America is expected to dominate the global cosmetic surgery market share during the forecast period. In 2022, the region secured 35.8% of the global revenue. The domination of the region can be attributed to the emergence of various licensed medical spas in the region.
Various licensed key players offer developed cosmetic surgical products which is expected to fuel the market in North America during the forecast period. In April 2022, MedSpa Partners Inc. announced expansion into the United States by welcoming top facial plastic surgeon Dr. Steven Dayan and his Chicago, IL-based team to its top-tier medical aesthetics platform.
In another instance, in June 2022, Lakewood Ranch, Florida-based Vision Source announces the launch of an in-house medical spa offering facial and aesthetic services. The med spa specializes in skin rejuvenation and anti-aging aesthetic treatments. Attributed to such factors, the market in North America is expected to dominate the global market for cosmetic surgery products market during the forecast period.
Country | United States |
---|---|
2022 Value Share in Global Market | 32.9% |
The United States cosmetic surgery products market has witnessed substantial growth in recent years, driven by the increasing desire for physical enhancement, advancements in medical technology, and rising disposable incomes. There is a noticeable shift towards non-invasive or minimally invasive procedures. Treatments like Botox, dermal fillers, and laser-based therapies are gaining popularity due to their reduced downtime, lower risks, and effective results. The American Society of Plastic Surgeons (ASPS) reported that in 2020, there were 15.5 million cosmetic procedures conducted in the United States, with 13.2 million of them categorized as minimally invasive. Consumers are increasingly seeking personalized solutions tailored to their specific needs and preferences. Cosmetic surgeons and product manufacturers are offering customized treatments to meet these demands. Celebrity endorsements and social media influence have a significant impact on the market in the United States. Popular celebrities sharing their positive experiences with cosmetic procedures drive consumer interest and contribute to the market growth.
In 2022, the European market for cosmetic surgery products market garnered 24.4% of the global revenue. The development of the region can be attributed to the increasing demand for facial injectables.
As per an article published in 2-21, plastic surgeons in the UKrevealed that the demand for injectable cosmetic procedures like botulinum toxin by the male population has increased by 70%.
Players in the market are taking various initiatives that is likely to benefit the regional industry growth in the coming time. For instance, in March 2022, Allergan Aesthetics, an AbbVie company announced the launch of HArmonyCa with lidocaine across Europe. It is a dual-effect hybrid injectable with two active ingredients, calcium hydroxyapatite, and hyaluronic acid. Such factors are expected to augment the regional market during the forecast period.
Country | United Kingdom |
---|---|
Value CAGR (2023 to 2033) | 6.6% |
Country | Germany |
---|---|
2022 Value Share in Global Market | 5.4% |
The United Kingdom cosmetic surgery products market has witnessed steady growth over the years, driven by rising disposable incomes, changing beauty standards, advancements in medical technology, and an aging population. There is a growing awareness and preference for natural and organic cosmetic surgery products in the United Kingdom. Consumers are seeking products with fewer chemicals and more sustainable ingredients, reflecting the overall trend towards eco-friendly and cruelty-free options. The country attracts a significant number of medical tourists seeking cosmetic procedures. The country's reputation for high-quality healthcare services and skilled practitioners makes it an appealing destination for international patients.
The Germany cosmetic surgery products market has experienced significant growth in recent years, driven by increasing consumer awareness, changing beauty standards, and advancements in medical technology. Germany's reputation for high-quality healthcare facilities and skilled surgeons has made it a popular destination for cosmetic procedures, further boosting the market. Consumers are showing a preference for natural and organic cosmetic surgery products. Manufacturers are incorporating organic ingredients and eco-friendly packaging to meet this demand. Consumers here generally prefer subtle, natural-looking results from cosmetic procedures. The less-is-more approach is gaining popularity, with patients seeking treatments that enhance their natural beauty rather than radically altering their appearance.
As per the analysis, the Asia Pacific market for cosmetic surgery products is expected to be the most lucrative market during the forecast period. Increasing demand for anti-aging procedures is expected to benefit the regional market in the coming period. Ongoing development in the dermal fillers acts as an opportunity for the region.
Moreover, players in the region are taking various initiatives to strengthen their position in the market. For instance, In September 2020, Croma Pharma GmBH announced a new Joint Venture partnership in China with China National Biotech Group Company Ltd. (“CNBG”). The initiative is projected to surge the presence of the company in the Asia-Pacific region and contribute to the revenue of the company in the forecast period.
Country | Value CAGR (2023 to 2033) |
---|---|
China | 11.4% |
India | 9.4% |
Country | Japan |
---|---|
2022 Value Share in Global Market | 7.5% |
The China cosmetic surgery products market has experienced rapid development, becoming one of the world's leading markets for aesthetic procedures. The rising popularity of cosmetic surgery is attributed to factors such as urbanization, globalization, and the influence of social media, which have led to the adoption of Western beauty ideals. China has emerged as a popular destination for medical tourism, attracting patients from neighboring Asian countries seeking cosmetic surgery. The availability of high-quality medical facilities and relatively affordable treatment costs have contributed to this trend. The popularity of Korean and Japanese beauty trends has profoundly impacted consumers' preferences for specific aesthetic features in China. As a result, procedures like double eyelid surgery and rhinoplasty have become increasingly common. The rise of e-commerce and social media platforms has facilitated easy access to cosmetic surgery products, as well as the sharing of before-and-after results and patient experiences. This has contributed to increased consumer awareness and acceptance.
India has witnessed a shift in societal attitudes towards beauty and aesthetics, leading to an upsurge in demand for cosmetic surgery products. Rapid urbanization and exposure to global beauty standards have fueled the desire for physical enhancements. The booming beauty and skincare industry has indirectly contributed to the growth of the cosmetic surgery products market. The increasing emphasis on skincare has influenced consumers to seek long-term solutions for their aesthetic concerns. India's booming entertainment industry, including film, television, and social media, heavily influences beauty standards and drives the desire for cosmetic enhancements among celebrities and the general public alike. Social media platforms, especially Instagram and YouTube, are full of beauty content showcasing various cosmetic procedures and transformations.
Japan cosmetic surgery products market is characterized by a growing consumer base seeking non-invasive and minimally invasive procedures. Consumers are more inclined toward treatments that require little to no downtime and have minimal side effects. A desire for quick results and convenience drives this trend. Consumers tend to favor natural-looking results that enhance their features without appearing overdone. Japan's beauty ideals are deeply rooted in its culture, emphasizing clear and youthful skin, symmetrical features, and a delicate appearance. These preferences heavily influence the types of procedures and products that are popular in the market. Japan also has a rapidly aging population, leading to an increased demand for anti-aging procedures and products.
MirrorMe3D (USA), Medical Augmented Intelligence (MAI), Numex (Switzerland), 3D Life (Greece), Sensus3D (Argentina), Glamyo (India), Veleza (UK), Blusho (UK), Sisu (USA), among others, are some of the emerging names in the market. Startups are obtaining funding, which will augment the market size in the assessment period.
Key players in the global cosmetic surgery products include Mentor Corporation, Allergan, Candela Corp, Lumenis Ltd., Cutera Inc, Palomar Medical, Iridex Corp, DermaMed Pharmaceutical Inc, Solta Medical, Medtronic plc, Syneron Medical Ltd., Johnson & Johnson Services, Inc. Cynosure Inc., and several others.
Key Updates from the Industry
The value of cosmetic surgery products market is US$ 19.09 billion in 2023.
The demand growth of cosmetic surgery products is 8.1% CAGR.
Increasing demand for non-invasive procedures is trending in the market.
The target market for cosmetic surgery products is clinics.
North America is at the forefront of the market, securing a total of 35.8% market share.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Cosmetic Surgery Implants 5.3.2. Breast Implants 5.3.3. Chin & Cheek Implants 5.3.4. Injectables 5.3.5. Botulinum Toxin 5.3.6. Soft Tissue Fillers 5.3.7. Dermal Fillers 5.3.8. Absorbable Fillers 5.3.9. Non-Absorbable Fillers 5.3.10. Cosmetic Surgery Lasers 5.3.11. Ablative Laser 5.3.12. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Face 6.3.2. Upper Body 6.3.3. Breasts 6.3.4. Hands 6.3.5. Stomach 6.3.6. Lower Bod 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Clinics 7.3.4. Universities and Research Centers 7.3.5. Homecare Settings 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Application 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Allergan 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Smith & Nephew 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Candela Corp 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Cutera Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Lumenis Ltd. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Palomar Medical 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Iridex Corp. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Solta Medical 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. DermaMed Pharmaceutical Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Medtronic 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Johnson & Johnson 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Cynosure Inc. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Alma Lasers Ltd. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Sanofi 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Bausch Health 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Recommendations
Explore Healthcare Insights
View Reports